| 产品详情 |
| Edit |   |
|---|
| Product Name | Trastuzumab (Herceptin®) Immunogenicity BioAssay™ ELISA Kit |
|---|
| Description | Trastuzumab (Herceptin®) is a humanized recombinant monoclonal antibody used for the treatment of primary breast cancers overexpressing human epidermal growth factor 2 (HER2). Intended Use: This kit allows researchers to qualitatively monitor the presence of anti-Trastuzumab antibodies in biological matrices like serum and plasma. Precision: Intra-assay CV: <10% Inter-assay CV: <10% Principle of the Assay: This immunogenicity assay employs the bridging ELISA technique. Capture antibody has been pre-coated onto a 96-well microplate. Quality control and test samples are pipetted into the appropriate wells. Anti-Trastuzumab present in biological matrices is bound by the immobilized capture antibody. After washing away any unbound substances, secondary antibody is added to the wells and after a final wash a detection reagent is added. The plate is washed to remove any unbound antibody-enzyme reagent and a substrate solution is added to the wells for color development. Color development is |
|---|
| Size | 96 tests |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 384869 |
|---|
| Price | |
|---|
| Order / More Info | Trastuzumab (Herceptin®) Immunogenicity BioAssay™ ELISA Kit from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|